Medical Therapy of Fibrostenotic Crohn's Disease - Wikidata - awgldk - TriplyDB

Medical Therapy of Fibrostenotic Crohn's Disease

Medical Therapy of Fibrostenotic Crohn's Disease

http://www.wikidata.org/entity/Q26777724

about

Bowel Thickening in Crohn's Disease: Fibrosis or Inflammation? Diagnostic Ultrasound Imaging Tools.

P2860

Q39046622-B88EFAFB-0B4D-4C77-8AD8-EF9CA8D15064

P2860

Medical Therapy of Fibrostenotic Crohn's Disease

http://www.wikidata.org/entity/Q26777724

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Medical Therapy of Fibrostenotic Crohn's Disease

@ast

Medical Therapy of Fibrostenotic Crohn's Disease

@en

Medical Therapy of Fibrostenotic Crohn's Disease

@nl

type

label

Medical Therapy of Fibrostenotic Crohn's Disease

@ast

Medical Therapy of Fibrostenotic Crohn's Disease

@en

Medical Therapy of Fibrostenotic Crohn's Disease

@nl

prefLabel

Medical Therapy of Fibrostenotic Crohn's Disease

@ast

Medical Therapy of Fibrostenotic Crohn's Disease

@en

Medical Therapy of Fibrostenotic Crohn's Disease

@nl

P1433

Q26777724-F0E9E96C-40EE-4313-B4AF-96147FE62A7F

P1476

Q26777724-2C469472-B3BA-4A8D-8B78-865685223564

P2860

Q26777724-0611DC97-1150-41C3-AFD6-4AA99DD75152

Q26777724-09B507FC-E0CE-48C1-BA65-57972F2727C8

Q26777724-09BF5CF2-0761-483B-9EA3-CE25CB4DA2BF

Q26777724-0A290AFA-4E6B-4C8C-8690-89B59800F7EA

Q26777724-0B96EF05-C941-449E-88B4-81DC69D1BF08

Q26777724-12D4D0D8-2EDF-4BBC-A071-D9ABD8E4CC5E

Q26777724-15203481-2D2A-4550-A86D-C2DF76D60AB6

Q26777724-1546506C-E6A6-48ED-A620-F64510EA9B82

Q26777724-16FD4240-62A5-4269-9FC4-49327B73253F

Q26777724-1989A161-05BC-44C6-BC06-E48A18A48B55

P304

Q26777724-1B67842A-6021-40CA-AD35-DF4D0D31BFC8

P31

Q26777724-7507F0AE-9711-4095-9B43-FDA002B6060C

P356

Q26777724-2214A120-ABFE-461F-9DF4-4CF701E27501

P407

Q26777724-9B8CDB55-769D-495B-9275-9F019EAB5BDF

P433

Q26777724-1EA32D8C-239E-481E-8A23-D590F17AC1BE

P478

Q26777724-D1DEF37B-378B-4499-ACEB-A6F44E9C598B

P50

Q26777724-21CF6143-530F-44F7-B654-24021E25E524

P577

Q26777724-21CFA28F-D92F-4EE0-8219-FBC227E0971F

P698

Q26777724-F0A0C1B0-9043-49CC-B7FA-30A3DA0B8FFA

P921

Q26777724-FDE1C9D1-BBFA-4675-8234-C5BDB7218D6D

P932

Q26777724-621C3CCF-D3BA-439E-BB77-89F507922F49

P356

P1433

Viszeralmedizin

P1476

Medical Therapy of Fibrostenotic Crohn's Disease

@en

P2860

Can we prevent, reduce or reverse intestinal fibrosis in IBD?

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

The peroxisome-proliferator-activated gamma receptor and chronic inflammatory bowel disease (PPARgamma and IBD)

IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis

Noncanonical TGF-beta pathways, mTORC1 and Abl, in renal interstitial fibrogenesis

Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.

Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated

Lebrikizumab treatment in adults with asthma.

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.

P304

259-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000435868

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Britta Siegmund

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26557834

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease

P932

4620591

http://www.w3.org/2001/XMLSchema#string